Enterococci are ubiquitous inhabitants of the gastrointestinal (GI) tract. However, antibiotic-resistant enterococci are also major causes of hospital-acquired infections. Enterococci are intrinsically resistant to cephalosporins, enabling growth to abnormally high densities in the GI tract in patients during cephalosporin therapy, thereby promoting dissemination to other sites where they cause infection. Despite its importance, many questions about the underlying basis for cephalosporin resistance remain. A specific two-component signaling system, composed of the CroS sensor kinase and its cognate response regulator (CroR), is required for cephalosporin resistance in Enterococcus faecalis, but little is known about the factors that control this signaling system to modulate resistance. To explore the signaling network in which CroR participates to influence cephalosporin resistance, we employed a protein fragment complementation assay to detect protein-protein interactions in E. faecalis cells, revealing a previously unknown association of CroR with the HPr protein of the phosphotransferase system (PTS) responsible for carbohydrate uptake and catabolite control of gene expression. Genetic and physiological analyses indicate that association with HPr restricts the ability of CroR to promote cephalosporin resistance and gene expression in a nutrient-dependent manner. Mutational analysis suggests that the interface used by HPr to associate with CroR is distinct from the interface used to associate with other cellular partners. Our results define a physical and functional connection between a critical nutrient-responsive signaling system (the PTS) and a two-component signaling system that drives antibiotic resistance in E. faecalis, and they suggest a general strategy by which bacteria can integrate their nutritional status with diverse environmental stimuli.
nterococci are ubiquitous Gram-positive bacteria usually found as commensals of the gastrointestinal (GI) tract in humans, animals, and insects. In the competitive environment of the GI tract, the ability to utilize a diverse repertoire of nutrients for growth may represent an important selective advantage. Enterococci can utilize a wide variety of carbohydrates for growth (1) (2) (3) , a trait that is reflected in the abundance of carbohydrate uptake and utilization pathways identified in the Enterococcus faecalis genome (4) . The enterococcal genome is especially replete with genes encoding components of the phosphoenol pyruvate (PEP)-dependent phosphotransferase system (PTS) that is widely used by bacteria both to transport carbohydrates into the cell and to control gene expression in response to nutrient availability (see references 5 and 6 for thorough reviews). PTSs mediate transport and phosphorylation of substrate carbohydrates through the coupled action of carbohydrate-specific transporters (called "EIIs") and the general PTS components EI and HPr. EI and HPr participate in sequential phosphotransfer reactions in which phosphoryl groups derived from PEP are shuttled from the EI kinase through HPr to an EII, and ultimately to a carbohydrate substrate upon transport by its cognate EII (see Fig. S1 in the supplemental material).
The PTS also performs a signal transduction function in response to carbohydrate availability by modulating the activity of transporters, enzymes, and regulators of gene expression (to control carbon catabolite regulation) through protein-protein interaction (PPI) or by phosphorylation. In low-GC Gram-positive bacteria, HPr plays a critical role in this signaling process by directly phosphorylating specific regulatory proteins to control their activity (7) (8) (9) and by engaging in PPI with the transcriptional regulator CcpA (10, 11) to modulate transcription of target genes.
Association of HPr with CcpA is controlled by phosphorylation of HPr at a regulatory site (Ser46) distinct from the site used in phosphotransfer for carbohydrate uptake (His15), such that only the P-Ser-HPr isoform associates with CcpA to regulate gene expression. Phosphorylation of Ser46 on HPr is controlled by a dedicated HPr kinase/phosphorylase (HprK) (12) , whose relative kinase and phosphorylase activities are allosterically modulated in response to metabolic intermediates derived from carbohydrate catabolism. Thus, the HPr protein of the PTS occupies a central position in the carbohydrate metabolic and regulatory network of Gram-positive bacteria, in which its activity depends on PPI with numerous cellular factors.
Enterococci are considered pathobionts, i.e., normal members of the human microbiota that have the potential to cause disease in certain circumstances. Indeed, antibiotic-resistant enterococci are major causes of hospital-acquired infections (13) and therefore represent a serious public health problem. A well-known risk factor for the acquisition of enterococcal hospital-acquired infections is prior therapy with broad-spectrum cephalosporins (14) , antibiotics that belong to the ␤-lactam family and interfere with cell wall biosynthesis by inhibiting the penicillin-binding proteins (PBPs) that cross-link peptidoglycan. Enterococci naturally exhibit resistance to cephalosporins, enabling rampant proliferation to achieve abnormally high densities in the GI tract in patients during cephalosporin therapy (15) , thereby promoting dissemination to other sites where they cause infection. Although intrinsic cephalosporin resistance is a trait common to essentially all isolates of E. faecalis, our understanding of the genetic and biochemical basis underlying cephalosporin resistance in enterococci remains incomplete. A specific two-component signal transduction system, composed of a transmembrane sensor histidine kinase (CroS) and its cognate response regulator (CroR), is required for intrinsic cephalosporin resistance (16, 17) . However, little is known about the molecular basis for the role of CroRS in promoting resistance, such as the identities of the signals that trigger activation or the CroR-dependent genes that drive resistance.
To explore the underlying signaling network in which CroRS participates to enhance cephalosporin resistance, we adapted a previously described (18, 19) protein fragment complementation assay (PCA) to probe for new protein-protein interactions in E. faecalis. This approach takes advantage of the observation that murine dihydrofolate reductase (mDHFR) can be separated into 2 fragments, designated F [1, 2] and F [3] , that when coexpressed cannot fold into an enzymatically competent form. However, if the F [1, 2] and F [3] fragments are fused to a pair of interacting proteins, association of the interacting fusions brings the F [1, 2] and F [3] fragments into proximity and enables proper folding to form functional mDHFR. Reconstitution of mDHFR activity therefore serves as an in vivo detector of PPI between the fused protein partners. In bacteria, this PCA is implemented by inhibiting the endogenous bacterial DHFR with the antibiotic trimethoprim (TMP), which binds bacterial DHFR with an ϳ12,000-fold higher affinity than that for mDHFR. Because DHFR activity can be required for bacterial growth, cells coexpressing F [1, 2] and F [3] fusions will grow in the presence of TMP only if the fusion partners undergo PPIs in vivo. Using this strategy, we found that the HPr protein of the PTS associates with CroR in vivo to influence cephalosporin resistance and gene expression in a nutrient-dependent manner. Mutational analysis suggests that the interface used by HPr to associate with CroR is distinct from that used to associate with its other known cellular partners. These results establish a formerly unknown physical and functional connection between the major signaling system responsible for monitoring the nutritional status of the cell via carbohydrate uptake (the PTS) and a two-component signaling system that drives antibiotic resistance in E. faecalis. Given the widespread cooccurrence of two-component signaling systems and the PTS in bacteria, this may represent a general mechanism by which bacteria integrate information about their nutritional status with a variety of sensory responses to extracellular stimuli.
MATERIALS AND METHODS
Bacterial strains, growth media, and chemicals. Bacterial strains and plasmids used in this study are listed in Table S3 in the supplemental material. E. faecalis strains were grown in half-strength brain heart infusion (hBHI), Mueller-Hinton broth (MHB), or the semidefined MM9YE medium (20) at 37°C. Escherichia coli strains were grown in lysogeny broth (LB) or hBHI. Concentrations of antibiotics were as follows: erythromycin (Em), 100 g/ml in hBHI (E. coli) or 10 g/ml (E. faecalis); chloramphenicol (Cm), 10 g/ml. All antibiotics and chemicals were obtained from Sigma-Aldrich unless stated otherwise. mDHFR PCA. We adapted the in vivo PCA based on murine dihydrofolate reductase (mDHFR) that has been used in other bacterial systems (18, 19) . Coexpression of mDHFR fusions in E. faecalis was achieved by introducing compatible expression plasmids (derivatives of pJRG8 and pJRG9) that encoded C-terminal fusions of proteins to be tested to the N-terminal end of the F [1, 2] or F [3] mDHFR fragment. All mDHFR fusions were to full-length E. faecalis proteins and included a (Gly 4 Ser) 2 flexible linker between the protein of interest and the fused mDHFR fragment. Expression of the fusions was driven by the constitutive P23s promoter carried in pJRG8 and pJRG9. The (Gly 4 Ser) 2 linker and mDHFR F [1, 2] and F [3] fragments were obtained by PCR amplification from pUAB100 and pUAB200 (19) , respectively, and included a primer-encoded in-frame SpeI restriction site upstream of the linker. Genes encoding proteins to be fused were amplified (with an in-frame SpeI restriction site in place of the stop codon) by PCR and assembled with the appropriate mDHFR fragment by using the SpeI restriction site. The intact fusions were then introduced downstream of the P23s promoter in pJRG8 (for F [1, 2] fusions) or pJRG9 (for F [3] fusions) by using primer-encoded restriction sites. To test for reconstitution of mDHFR activity indicative of protein-protein association, a minimum of three independent transformants of E. faecalis coexpressing pairs of mDHFR fusions were grown on MH agar supplemented with Cm and Em (for plasmid maintenance) and trimethoprim at 1 g/ml.
Coimmunoprecipitation assay. For coimmunoprecipitations, plasmids expressing proteins of interest fused to the 8-amino-acid Strep-tag epitope (WSHPQFEK) were constructed. These fusions were coexpressed with the existing F [3] fusions in E. faecalis (i.e., no F [1, 2] fusions were present), and strains were grown in MHB supplemented with Cm and Em to an optical density at 600 nm (OD 600 ) of 0.2 to 0.25. Bacteria were collected from 100-ml cultures and washed one time with fresh MHB. Cells were resuspended in 400 l of lysis buffer (5 mM EDTA, 50 mM Tris, 1 M NaCl, 2% Tween 20, 1ϫ protease inhibitor cocktail [Thermo Scientific], and 0.5ϫ phosphatase inhibitor cocktail [Thermo Scientific], pH 7.4). Bacteria were mechanically disrupted by bead beating with 0.1-mm zirconia-silica beads. After removal of beads and unbroken cells by centrifugation, whole-cell lysates were incubated with antiserum raised against a C-terminal peptide of mDHFR (Sigma) for 1 h at 4°C with gentle agitation. Protein A agarose beads (75 l; Invitrogen) were added to the mixture and incubated for 1 h at 4°C with gentle agitation. Beads were collected by passing the sample through a Micro Bio-Spin chromatography column (Bio-Rad) and were washed three times with wash buffer (lysis buffer without protease and phosphatase inhibitors). Bound proteins were eluted by boiling in Laemmli sodium dodecyl sulfate (SDS) sample buffer. Samples were subjected to SDS-PAGE followed by Western blotting with anti-Strep (GenScript) or anti-DHFR C-terminal primary antibody, used at a dilution of 1 to 5,000, followed by horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG secondary antibody (Invitrogen).
Plasmid constructs. Plasmid pBK200 was used to express Streptagged proteins for coimmunoprecipitation. Plasmid pBK200 was constructed by amplifying the p23 promoter from pDL278p23 (21) with primer-encoded EcoRI/BamHI sites, followed by cloning into similarly digested pAT18. To construct a plasmid that expresses C-terminally Strep-tagged CroR, a PCR amplicon carrying croR-Strep was generated and cloned into pBK200 by using primer-encoded BamHI/SphI sites to create plasmid pHS11. To construct a plasmid expressing C-terminally Strep-tagged EF1714, Gateway technology (Invitrogen) was used. E. faecalis open reading frames (ORFs) of interest were amplified with a forward primer containing an attB1 sequence and a reverse primer containing an attB2 sequence and were used to create entry clones via BP recombination reaction with the donor vector pDONR221 (Invitrogen). The pBK200 expression vector was converted to a destination vector (pHH6) by using the Gateway vector conversion system (Invitrogen) such that, after LR recombination, ORFs of interest would be fused at the Cterminal end to the Strep tag. The expression clone pHS12 was con-structed by LR recombination reaction between the destination vector pHH6 and the EF1714 entry clone. All Gateway recombination reactions were transformed into One Shot Mach 1 T1 phage-resistant chemically competent E. coli (Invitrogen). The pJRG8 expression vector was converted to a destination vector (pHH3) by using the Gateway vector conversion system such that, after LR recombination, ORFs of interest would be fused at the C-terminal end to F [1, 2] . To create expression clone pHS13, the EF1714 entry clone was transferred to the destination vector pHH3 by the LR recombination reaction. The pJRG9 expression vector was converted to a destination vector (pHH8) by using the Gateway vector conversion system such that, after LR recombination, ORFs of interest would be fused at the C-terminal end to F [3] . To create the expression vector pHS14, LR reaction recombination was carried out between the EF1039 entry clone and the destination vector pHH8.
Construction of E. faecalis mutants. Markerless allelic exchange was used to construct mutant strains of E. faecalis as previously described (22) . The deletion mutants were in frame, and all mutants were unmarked. All mutants for susceptibility analyses were constructed in E. faecalis OG1, which lacks point mutations that provide resistance to rifampin and fusidic acid in strain OG1RF, to avoid any potential effect of these mutations on the phenotype. Mutant alleles were constructed and introduced into pCJK218 by using either Gibson assembly (23) or primer-encoded restriction sites. The ⌬ptsH2 allele retains the coding sequence for 14 amino acids at the N-terminal end and 7 amino acids at the C-terminal end (ϳ76% of the ORF is deleted), which were retained in the mutant in an attempt to avoid perturbing the expression of adjacent genes. Similarly, the ⌬croR2 allele retains the coding sequence for 45 amino acids at the N-terminal end and 12 amino acids at the C-terminal end (ϳ75% of the ORF is deleted).
Antibiotic susceptibility. MICs for antibiotics were determined with aerobic liquid cultures after 24 h at 37°C by using a microtiter plate serial dilution method in a Bioscreen C plate reader (Oy Growth Curves Ab, Ltd.). Twofold dilutions of antibiotics in the indicated growth medium were prepared in the wells of a 100-well honeycomb microtiter plate. Bacteria from stationary-phase cultures were inoculated into each well, to a cell density of ϳ10 5 CFU/ml. For MIC determinations performed in MHB, overnight cultures were performed in MHB; for MIC determinations in MM9YE with various nutrient supplements, overnight cultures were performed in MM9YE supplemented with 0.1% glucose, and bacteria were washed in unsupplemented MM9YE prior to inoculation for susceptibility analysis. Plates were incubated at 37°C for 24 h, with brief shaking and measurement of the OD 600 at 15-min intervals. The lowest concentration of antibiotic that prevented growth was recorded as the MIC.
Screen to identify noninteracting point mutants of HPr. We exploited the mDHFR PCA to identify point mutants of HPr that were impaired in association with CroR in vivo. Error-prone PCR was used to introduce mutations into ptsH as described previously (24), with slight modifications. Briefly, E. faecalis OG1RF genomic DNA was used at a concentration of 1 g per PCR with error-prone master mix (10 mM Tris, pH 8.3, 50 mM KCl, 7 mM MgCl 2 , 1 mM dCTP, 1 mM dTTP, 0.2 mM dATP, 0.2 mM dGTP, 0.05 M MnCl 2 , and 0.05 U/l Taq polymerase), and 10, 12, and 17 PCR cycles were used. The error-prone PCR products were pooled and introduced into pLMS152 to replace the wild-type ptsH gene, using primer-encoded restriction sites. A mutant library of approximately 5,300 clones was recovered from E. coli TOP10 and pooled for plasmid extraction. The mutant library was introduced into E. faecalis OG1RF carrying pLMS3289F12. Approximately 1,200 clones were selected using a QP Expression colony-picking robot (Genetix) and were arrayed in individual wells of 96-well microtiter plates. After overnight growth in MHB supplemented with Cm and Em, cultures were transferred to MH agar plates (also supplemented with Cm and Em) containing or lacking trimethoprim (1 g/ml), using a 96-pin replicator. After incubation, colonies that were defective at growth with trimethoprim were recovered from the control plate (no trimethoprim) and analyzed further by immunoblotting for expression of full-length HPr-F [3] , using an antibody against the C-terminal fragment of mDHFR (Sigma). Clones exhibiting impaired growth in the presence of trimethoprim (reflecting impaired association with CroR) that expressed wild-type levels of full-length HPr-F [3] were reintroduced into fresh E. faecalis competent cells to confirm their phenotype. The sequences of ptsH genes from clones of interest were subsequently determined to identify the mutation responsible.
␤-Galactosidase activity measurements. Bacteria carrying the croR=-lacZ reporter plasmid (pCJK106) were cultured in MM9YE supplemented with either 0.1% glucose, 0.1% GlcNAc, 0.2% pyruvate, or 0.1% citrate at 37°C. Ceftriaxone was added to early-exponential-phase cells at 4ϫ MIC, and incubation continued for 2 h before harvest of the bacteria. ␤-Galactosidase activity was determined in cells permeabilized with SDS and chloroform as previously described (22) .
RESULTS
CroR interacts with HPr in E. faecalis. Protein-protein interactions (PPIs) are essential for most cellular processes. We hypothesized that factors required for cephalosporin resistance in E. faecalis, such as CroR, might participate in as yet unknown PPIs in vivo that regulate their function. Identification of such PPIs would therefore reveal new connections in the pathways mediating cephalosporin resistance in E. faecalis. To probe for such PPIs in E. faecalis, we adapted the in vivo PCA based on mDHFR that has been used in other bacterial systems (18, 19) .
To test for functionality of the mDHFR PCA in E. faecalis, we took advantage of the well-known PPIs of the HPr protein from the PTS, particularly the interaction of HPr with its regulator HprK (25, 26) . Coexpression of HprK-F [1, 2] and HPr-F [3] fusions in E. faecalis led to enhanced growth in the presence of TMP (colony formation at 10 Ϫ2 dilution) ( Fig. 1 ) that did not occur when either fusion was expressed alone or when HPr-F [3] was coexpressed with a randomly chosen control fusion, EF1714-F [1, 2] (growth only in undiluted inoculum) (Fig. 1) , indicating that the mDHFR PCA was capable of specifically detecting known PPIs in E. faecalis cells. We also observed enhanced growth in the presence of TMP when HPr-F [1, 2] and HPr-F [3] fusions were coexpressed (colony formation at 10 Ϫ3 dilution), suggesting the existence of HPr homodimers. HPr is generally thought to exist as a monomer in cells (5), so it remains unclear if this represents authentic homodimerization or if HPr fusions are brought into proximity through their association with an additional factor in the context of a larger protein complex (such as a CcpA homodimer [27] ) to enable reconstitution of mDHFR activity.
As an additional test of the mDHFR PCA, we probed whether we could detect dimerization of the CroR response regulator, a member of the OmpR family of response regulators, given that OmpR and related response regulators bind DNA as dimers (28) . Indeed, coexpression of CroR-F [1, 2] and CroR-F [3] resulted in enhanced growth in the presence of TMP (colony formation at 10 Ϫ3 dilution) that did not occur when either fusion was expressed alone or when CroR-F [1, 2] was coexpressed with a randomly chosen control fusion, EF1039-F [3] , consistent with in vivo dimerization of CroR (Fig. 1) . Thus, mDHFR PCA successfully detected 2 known PPIs in E. faecalis cells in a specific manner, indicating that it could serve as a useful tool for the identification of as yet unknown PPIs. As an additional control for the CroR dimerization analysis, we constructed an E. faecalis strain coexpressing CroR-F [1, 2] and HPr-F [3] . Surprisingly, we observed robust growth in the presence of TMP for this strain (colony formation at 10 Ϫ4 dilu-tion) (Fig. 1) , indicating a previously unknown association between CroR and HPr in E. faecalis cells.
To confirm this new PPI by a different approach, we performed coimmunoprecipitation studies on E. faecalis cell lysates. New E. faecalis strains were constructed that coexpressed the F [3] fusions in combination with an epitope-tagged (Strep tag) version of the partner protein (i.e., no F [1, 2] fusions were present in these strains). Protein complexes were immunoprecipitated from whole-cell lysates by using an anti-F [3] antibody under stringent conditions. We found that CroR-Strep coimmunoprecipitated with HPr-F [3] (Fig. 2) , consistent with the hypothesis that these proteins associate with each other in vivo. As controls for the specificity of coimmunoprecipitation, CroR-Strep was not recovered from a strain coexpressing the noninteracting control protein EF1039-F [3] (Fig. 2 ) (nor from a strain completely lacking an F [3] fusion protein). Similarly, immunoprecipitation of HPr-F [3] that was coexpressed with the noninteracting control protein EF1714-Strep did not result in coprecipitation, demonstrating the specificity of CroR-HPr coprecipitation. Thus, in combination with the in vivo PCA data, these results indicate that CroR and HPr specifically associate with each other in E. faecalis cells.
Mutation of HPr alters antibiotic resistance. If the association between CroR and HPr is physiologically relevant, mutations in HPr might be expected to alter the ability of CroR to promote cephalosporin resistance. To test this, we constructed an E. faecalis mutant carrying an in-frame deletion in the gene encoding HPr (⌬ptsH2). Antibiotic susceptibility tests on the mutant revealed that the ⌬ptsH2 mutant was significantly more resistant to the broad-spectrum cephalosporin ceftriaxone (Table 1) than the otherwise isogenic wild-type E. faecalis strain, suggesting that association of CroR with HPr limits the ability of CroR to promote cephalosporin resistance. The ⌬ptsH2 mutant could be complemented by expression of wild-type ptsH from a plasmid ( Table 2 ), confirming that the ⌬ptsH2 lesion is responsible for the phenotype. The ⌬ptsH2 mutant also exhibited enhanced resistance to another broad-spectrum cephalosporin, ceftazidime, but not toward a noncephalosporin antibiotic with a different cellular target (see Table S1 in the supplemental material). These results point toward a specific role for HPr in modulation of cephalosporin resistance (rather than a global change in the general stress response of the ⌬ptsH2 mutant), consistent with a model in which the effect of HPr on resistance is exerted through its association [1, 2] and F [3] fragments of mDHFR confers resistance to trimethoprim. E. faecalis strains coexpressing the indicated fusions were subjected to 10-fold serial dilutions and inoculated on MH agar supplemented with Cm and Em (for plasmid selection) in the presence or absence of trimethoprim. Coexpression of pairs of fusion proteins that are known or predicted to interact (HprK-HPr and CroR-CroR) led to enhanced growth in the presence of trimethoprim. The association between CroR and HPr was previously unknown. EF1714 and EF1039 represent randomly chosen E. faecalis control proteins that demonstrate the specificity of the CroR-HPr in vivo association. The host strain was E. faecalis OG1RF.
FIG 2
HPr and CroR coimmunoprecipitate from E. faecalis lysates. Association of CroR and HPr in whole-cell lysates of E. faecalis was assessed by coimmunoprecipitation with anti-F [3] antiserum. CroR or a randomly chosen E. faecalis control protein (EF1714) fused to a Strep tag was coexpressed with wild-type HPr, an HPr point mutant, or a randomly chosen E. faecalis control protein (EF1039) fused to mDHFR F [3] , as indicated. Lysates and immunoprecipitates were subjected to immunoblot analysis with antiserum specific for the Strep or F [3] fusions, revealing that CroR specifically coprecipitates with wildtype HPr. The host strain was E. faecalis OG1RF. "Lysates" corresponds to the whole-cell lysates used as input for coimmunoprecipitation; "IP" corresponds to the immune complexes recovered after coimmunoprecipitation.
with CroR. In accordance with such a model, hyperresistance of the ⌬ptsH2 mutant was mediated by CroR, as deletion of croR was epistatic to the ⌬ptsH2 mutation and resulted in loss of the hyperresistance phenotype in the double mutant (Table 1) .
HPr can be phosphorylated at His15, as an intermediate in the phosphorelay supporting uptake and phosphorylation of carbohydrate substrates, or at Ser46, the regulatory site that determines if HPr will bind CcpA to control gene expression (5) . To probe if phosphorylation at these sites is important for the ability of HPr to influence CroR-dependent cephalosporin resistance in E. faecalis, we expressed HPr mutants carrying either an H15A or S46A substitution in the ⌬ptsH2 mutant background. Susceptibility analyses revealed that the mutants bearing HPr with nonphosphorylatable substitutions exhibited hyperresistance to ceftriaxone (Table  2) , similar to the ⌬ptsH2 mutant, suggesting that phosphorylation influences the ability of HPr to associate with CroR. Consistent with this, when tested by the mDHFR PCA, Ala substitution mutants exhibited a moderately reduced ability to grow in the presence of TMP compared with wild-type HPr when coexpressed with CroR-F [1, 2] (colony formation was reduced 10-fold compared to that with wild-type HPr [see Association of CroR and HPr influences CroR-dependent cephalosporin resistance. Because of the central role that HPr plays in carbohydrate uptake and catabolite control of gene expression, we considered the possibility that pleiotropic effects of ptsH deletion might indirectly contribute to the cephalosporin hyperresistance phenotype. To specifically explore the physiological role of HPr-CroR association, we performed an unbiased screen using the mDHFR PCA to isolate HPr point mutants that had lost the ability to interact with CroR. Error-prone PCR was used to generate a pool of HPr-F [3] mutants that was introduced into E. faecalis for coexpression with CroR-F [1, 2] . Individual clones exhibiting reduced growth in the presence of TMP (in most cases, growth only in undiluted inoculum, indicating a lack of interaction between the HPr-F [3] mutant and CroR-F [1, 2] ) were subjected to immunoblotting to ensure that full-length HPr-F [3] fusions were expressed at levels comparable to that of the wildtype HPr-F [3] fusion. To exclude mutations that prevent HPr from adopting its proper overall folded conformation and/or that destabilize the folded conformation, we used the mDHFR PCA to assess if the expressed HPr mutants emerging from the initial screen retained the ability to associate with wild-type HPr. We reasoned that completely nonfunctional HPr mutants (e.g., mutants lacking a proper three-dimensional [3D] fold) would be expected to disrupt PPI not only with CroR but also with other HPr binding partners. Ten HPr mutants were identified that retained full growth on TMP when coexpressed with wild-type HPr-F [1, 2] but were specifically impaired in association with CroR (see Fig.  S3 and Table S2 in the supplemental material). Strikingly, with the exception of the V55D mutation, many of the mutations occur at positions in close proximity to each other in the 3D structure of HPr (29) , suggesting that they alter a functional surface of HPr that is required for association with CroR ( Fig. 3 ; see Discussion). For two mutants that specifically impaired association with CroR but not HPr in vivo (as judged by the ability to support growth on TMP), namely, the HPr E2G and E70G mutants, coimmunoprecipitation analyses of E. faecalis lysates revealed that the HPr mutants also no longer coprecipitated CroR-Strep ( Fig. 2; see Fig. S4 ). Thus, these results confirm that the HPr mutants isolated via mD-HFR screening are indeed defective at association with CroR and further indicate that the mDHFR PCA is a reliable reporter of in vivo PPI. To probe the function of the CroR-HPr association in vivo, we constructed E. faecalis mutants carrying noninteracting HPr alleles in the chromosomal ptsH gene. We tested if these HPr mutants were capable of performing their normal function in carbohydrate uptake by monitoring growth with the PTS substrates glucose and N-acetylglucosamine as carbon sources in a chemically defined medium. In this medium, the ⌬ptsH2 mutant exhibits a severe growth defect, presumably due to its inability to transport carbohydrates efficiently. Expression of the noninteracting HPr mutants restored wild-type growth in defined medium (Fig.  4) , indicating that the HPr mutants could support normal carbohydrate uptake via the PTS-mediated phosphorelay and that, presumably, these HPr mutants were therefore capable of interacting productively with their EI and EII partners that are required for transport. Thus, we inferred that the HPr point mutants were fully functional in the context of PTS-mediated carbohydrate uptake. However, analysis of cephalosporin susceptibility revealed that both HPr mutants examined exhibited an increase in cephalosporin resistance (Table 1) analogous to the increase in resistance observed upon deletion of HPr. We concluded that the enhanced resistance to cephalosporins exhibited by the ⌬ptsH2 mutant was not the result of pleiotropic effects on the cell secondary to deletion of ptsH but specifically reflected the loss of CroR-HPr association. Furthermore, enhanced cephalosporin resistance observed upon expression of noninteracting HPr mutants depends on CroR, as deletion of croR was epistatic to the ptsH point mutations and resulted in loss of the hyperresistance phenotype in the double mutants (Table 1) . Overall, the analyses of our noninteracting HPr point mutants are consistent with a model in which association of HPr with CroR limits the ability of CroR to promote cephalosporin resistance.
Growth substrate alters CroR-dependent resistance. Transport of carbohydrates by the PTS modulates the activity of HPr (5) . During active transport of rapidly metabolizable substrates via the PTS, the HPr protein rapidly shuttles phosphoryl groups between EI and EII via reversible phosphorylation at His15. Under these circumstances, HprK phosphorylates HPr at the regulatory site Ser46, leading to interaction with CcpA and binding of the P-Ser-HPr-CcpA complex to DNA to control gene expression (e.g., catabolite repression). In the absence of PTS substrates, however, HPr does not become phosphorylated at Ser46 or interact with CcpA to influence gene expression. Thus, we reasoned that changes in the activity of the PTS as a function of carbohydrate transport might modulate the level of cephalosporin resistance in E. faecalis through association of HPr with CroR. To explore this possibility, we performed antibiotic susceptibility analyses of cells grown with carbohydrates that are substrates of the PTS and compared the results with the susceptibility of cells grown with non-PTS carbon sources. Growth of wild-type E. faecalis on 2 non-PTS carbon sources (pyruvate and citrate) resulted in significantly enhanced levels of cephalosporin resistance compared to growth on the PTS substrates glucose and N-acetylglucosamine (Table 3 ). No such effect was observed for the ⌬croR2 mutant, indicating that CroR activity is required for this nutrient effect. Similarly, a marked nutrient-dependent change in ceftriaxone resistance was not observed for a mutant strain expressing a noninteracting HPr mutant (HPr E2G) ( Table 3 ), indicating that CroR mediates the nutrient effect as a function of its association with HPr. As a control, no change in resistance to chloramphenicol, a noncephalosporin antibiotic that impairs ribosome function, was observed during growth of wild-type E. faecalis on different carbon sources (Table 3) . Nutrient-dependent changes in cephalosporin resistance were also observed for a genetically distinct lineage of E. faecalis (E. faecalis T1) and for 2 lineages of the related enterococcal species Enterococcus faecium (Table 3) , indicating that this trait is widespread among enterococci. Thus, the activity of the PTS influences cephalosporin resistance in E. faecalis in a CroR-dependent manner, consistent with a model in which association of HPr with CroR in vivo modulates the ability of CroR to drive cephalosporin resistance.
To test if association with HPr alters the ability of CroR to drive transcription, we examined CroR-dependent gene expression in E. faecalis cells that had been cultured with various nutrient sources in the presence of ceftriaxone. Thus far, only a few CroRdependent promoters have been identified in E. faecalis, none of which drives expression of genes known to be required for cephalosporin resistance. However, many two-component signaling systems positively regulate their own synthesis, and previous studies indicate that this is true of the CroRS system (16, 30) . Therefore, we used activation of the croR promoter to monitor transcriptional activity of CroR. Strikingly, we found that levels of CroR-dependent gene expression correlated with resistance to ceftriaxone during growth on different nutrient sources. For example, growth of wild-type E. faecalis in glucose-or GlcNAc-containing medium led to diminished levels of gene expression compared to those with growth in citrate-or pyruvate-containing medium (Fig. 5) , consistent with the difference in ceftriaxone resistance observed in these medium types. In contrast, an E. faecalis mutant expressing HPr that is unable to associate with CroR (HPr E2G) exhibited substantially increased levels of CroR-dependent gene expression in glucose-and GlcNAc-containing medium compared to those of the wild type, reflecting the enhanced ceftriaxone resistance observed for this mutant. These results support a model in which association of CroR with HPr restricts the ability of CroR to drive its own gene expression, and likely that of other members in the CroR regulon, to promote resistance to cephalosporins in E. faecalis.
DISCUSSION
In this study, we employed an in vivo protein fragment complementation assay to reveal a previously unknown association of the two-component response regulator CroR with the HPr protein of the PTS. The following lines of evidence argue that CroR can be associated with HPr in E. faecalis cells: (i) specific reconstitution of mDHFR-dependent growth upon coexpression of complementary HPr and CroR fusions, (ii) specific coimmunoprecipitation of CroR with HPr from E. faecalis lysates under stringent conditions, (iii) specific loss of both mDHFR-dependent growth and coimmunoprecipitation upon expression of particular HPr missense mutants (i.e., the "noninteracting" mutants) that are otherwise functional, and (iv) phenotypic studies in which the level of cephalosporin resistance is inversely correlated with the ability of CroR to associate with HPr. It is worth noting that the specific version of CroR used for PCA was distinct from that used for coimmunoprecipitation; namely, for PCA we expressed a CroR-F [1, 2] fusion protein to permit reconstitution of mDHFR activity upon association with HPr-F [3] , whereas the coimmunoprecipitation studies were performed using CroR fused only to the 8-amino-acid Strep-tag epitope (no F [1, 2] fragment was present). This arrangement eliminates the possibility that an unanticipated artifact related to a particular CroR fusion is responsible for the observed association and reinforces the hypothesis that the association between CroR and HPr in E. faecalis is authentic. We attempted to demonstrate a direct interaction between CroR and HPr in vitro by using purified recombinant proteins in a pulldown assay, but we did not observe evidence for copurification in this format, despite multiple attempts. This is perhaps unsurprising, as both proteins can exist in posttranslationally modified forms (phosphorylated) in vivo, and it seems possible that only a particular combination of posttranslationally modified isoforms might interact with each other robustly enough to be detected by this approach. Alternatively, an additional, as yet unknown factor that is missing from our in vitro binding reaction mixtures may be required to facilitate association of CroR with HPr in vivo.
To explore the physiological function of HPr-CroR association, we isolated HPr mutants that had lost the ability to interact with CroR. We focused on HPr mutants that exhibited levels of full-length protein comparable to that of wild-type HPr-F [3] by immunoblotting and that retained their in vivo association with HPr to rule out mutants in which the HPr protein was incorrectly folded or unstable. Ten HPr mutants were identified that retained full growth on TMP when coexpressed with wild-type HPr-F [1, 2] but were specifically impaired in association with CroR (see Table  S2 in the supplemental material). Strikingly, with the exception of the V55D mutation, most of the mutations occurred at positions in close proximity to each other in the 3D structure of HPr, suggesting that they altered a functional surface of HPr that is required for association with CroR (Fig. 3) . In particular, mutations were found in several residues located in adjacent secondary structural elements: loops 2 and 6 (F29L, S31T, and G67V) and alpha helix C (E70G and several substitutions at M74 [see Table S2 ]). Q82 is also located on helix C, although it is further from the main cluster than M74, and we speculate that substitution at this site may interfere with proper positioning of the helix. The residue in ␤ strand A (HPr E2) is also found in this region of the structure. Collectively, these mutations suggest that residues from several secondary structural elements-namely, ␤ strand A, loops 2 and 6, and helix C-contribute to a molecular surface on HPr that is critical for association with CroR in vivo. Notably, this putative interaction surface is distinct from the surface of HPr that is known to mediate interactions with the other cellular partners of HPr, such as the EIIs and CcpA. Interactions with these partners are mediated by a common surface of HPr comprised of entirely different secondary structural elements-helix A and loops 1 and 5 (26, 27, 31, 32) -that are positioned on the opposite side of the HPr molecule from the mutations we have identified here. Additionally, the sites of phosphorylation on HPr (His15 and Ser46) are also positioned on the opposite side of HPr from the residues identified by our mutations. Thus, our mutagenesis results suggest that in vivo association of HPr with CroR occurs on a unique surface of HPr and may not inhibit or compete with interaction of HPr with its other PTS partners. The observation that 2 HPr mutants that were impaired at interaction with CroR were fully capable of supporting growth on carbohydrates via the PTS (Fig. 4) is consistent with the hypothesis that these interactions utilize distinct binding surfaces.
What is the physiological role of association between HPr and CroR? Our genetic and physiological analyses indicate that HPr restricts the ability of CroR to promote cephalosporin resistance and gene expression in a nutrient-dependent manner. Importantly, expression of HPr mutants that lacked the ability to associate with CroR-but were otherwise fully functional-led to nearly complete loss of the nutrient dependence of cephalosporin resistance, to enhanced cephalosporin resistance overall, and to elevated levels of CroR-dependent gene expression. These results are consistent with a model in which physical association of HPr with CroR prevents the ability of CroR to activate transcription of genes required for resistance, possibly by a simple "sequestration" mechanism in which CroR associated with HPr is unavailable to become phosphorylated, bind its target sequences in DNA, and stimulate transcription (or some subset of these activities). Alternatively, association with HPr may promote dephosphorylation of CroR-P. The fact that cephalosporin resistance is lowest in the presence of rapidly metabolizable PTS substrates suggests that the P-Ser-HPr isoform is the most proficient at inhibiting the ability of CroR to promote cephalosporin resistance, consistent with our observation that a strain expressing an HPr S46A mutant exhibits substantially enhanced ceftriaxone resistance (Table 2) .
Collectively, our results define a physical and functional connection between a critical nutrient-responsive signaling system (the PTS) and a two-component signaling system that drives antibiotic resistance in E. faecalis, revealing a previously unknown integration between the nutritional status of the cell and intrinsic antibiotic resistance. That such integration would be achieved through the PTS seems appropriate given the widespread role of the PTS in regulating gene expression (in the context of carbon catabolite control of gene expression) in response to the nutritional status of the environment. Given the widespread distribution of two-component signaling systems featuring OmpR-like response regulators (33) , as well as their cooccurrence with the PTS in many bacteria, we speculate that association of HPr with two-component response regulators may be a widespread phenomenon. Such interactions may represent a general strategy by which many bacteria integrate information about their nutritional status with a variety of distinct sensory responses to diverse extracellular stimuli.
